These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 28238733)
1. Fragmentation of the CRISPR-Cas Type I-B signature protein Cas8b. Richter H; Rompf J; Wiegel J; Rau K; Randau L Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):2993-3000. PubMed ID: 28238733 [TBL] [Abstract][Full Text] [Related]
2. Characterization of CRISPR RNA processing in Clostridium thermocellum and Methanococcus maripaludis. Richter H; Zoephel J; Schermuly J; Maticzka D; Backofen R; Randau L Nucleic Acids Res; 2012 Oct; 40(19):9887-96. PubMed ID: 22879377 [TBL] [Abstract][Full Text] [Related]
3. Modulating the Cascade architecture of a minimal Type I-F CRISPR-Cas system. Gleditzsch D; Müller-Esparza H; Pausch P; Sharma K; Dwarakanath S; Urlaub H; Bange G; Randau L Nucleic Acids Res; 2016 Jul; 44(12):5872-82. PubMed ID: 27216815 [TBL] [Abstract][Full Text] [Related]
4. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1. Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081 [TBL] [Abstract][Full Text] [Related]
5. A complex of Cas proteins 5, 6, and 7 is required for the biogenesis and stability of clustered regularly interspaced short palindromic repeats (crispr)-derived rnas (crrnas) in Haloferax volcanii. Brendel J; Stoll B; Lange SJ; Sharma K; Lenz C; Stachler AE; Maier LK; Richter H; Nickel L; Schmitz RA; Randau L; Allers T; Urlaub H; Backofen R; Marchfelder A J Biol Chem; 2014 Mar; 289(10):7164-7177. PubMed ID: 24459147 [TBL] [Abstract][Full Text] [Related]
6. In vitro assembly and activity of an archaeal CRISPR-Cas type I-A Cascade interference complex. Plagens A; Tripp V; Daume M; Sharma K; Klingl A; Hrle A; Conti E; Urlaub H; Randau L Nucleic Acids Res; 2014 Apr; 42(8):5125-38. PubMed ID: 24500198 [TBL] [Abstract][Full Text] [Related]
7. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis ofCas6b processing and CRISPR RNA stability. Richter H; Lange SJ; Backofen R; Randau L RNA Biol; 2013 May; 10(5):700-7. PubMed ID: 23392318 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog. Osawa T; Inanaga H; Sato C; Numata T Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071 [TBL] [Abstract][Full Text] [Related]
10. Approaches to study CRISPR RNA biogenesis and the key players involved. Behler J; Hess WR Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492 [TBL] [Abstract][Full Text] [Related]
11. Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus. Peng W; Li H; Hallstrøm S; Peng N; Liang YX; She Q RNA Biol; 2013 May; 10(5):738-48. PubMed ID: 23392249 [TBL] [Abstract][Full Text] [Related]
12. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family. Hrle A; Maier LK; Sharma K; Ebert J; Basquin C; Urlaub H; Marchfelder A; Conti E RNA Biol; 2014; 11(8):1072-82. PubMed ID: 25483036 [TBL] [Abstract][Full Text] [Related]
13. Essential requirements for the detection and degradation of invaders by the Haloferax volcanii CRISPR/Cas system I-B. Maier LK; Lange SJ; Stoll B; Haas KA; Fischer S; Fischer E; Duchardt-Ferner E; Wöhnert J; Backofen R; Marchfelder A RNA Biol; 2013 May; 10(5):865-74. PubMed ID: 23594992 [TBL] [Abstract][Full Text] [Related]
14. Substrate generation for endonucleases of CRISPR/cas systems. Zoephel J; Dwarakanath S; Richter H; Plagens A; Randau L J Vis Exp; 2012 Sep; (67):. PubMed ID: 22986408 [TBL] [Abstract][Full Text] [Related]
15. Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex. Majumdar S; Ligon M; Skinner WC; Terns RM; Terns MP Extremophiles; 2017 Jan; 21(1):95-107. PubMed ID: 27582008 [TBL] [Abstract][Full Text] [Related]
16. An active immune defense with a minimal CRISPR (clustered regularly interspaced short palindromic repeats) RNA and without the Cas6 protein. Maier LK; Stachler AE; Saunders SJ; Backofen R; Marchfelder A J Biol Chem; 2015 Feb; 290(7):4192-201. PubMed ID: 25512373 [TBL] [Abstract][Full Text] [Related]
17. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex. Takeshita D; Sato M; Inanaga H; Numata T J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex. Numata T; Inanaga H; Sato C; Osawa T J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598 [TBL] [Abstract][Full Text] [Related]